ACAD logo

ACADIA Pharmaceuticals Inc. (ACAD) Net income

annual net income:

$226.45M+$287.74M(+469.50%)
December 31, 2024

Summary

  • As of today (August 31, 2025), ACAD annual net profit is $226.45 million, with the most recent change of +$287.74 million (+469.50%) on December 31, 2024.
  • During the last 3 years, ACAD annual net income has risen by +$394.32 million (+234.90%).
  • ACAD annual net income is now at all-time high.

Performance

ACAD Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADincome statement metrics

quarterly net income:

$26.67M+$7.68M(+40.44%)
June 30, 2025

Summary

  • As of today (August 31, 2025), ACAD quarterly net profit is $26.67 million, with the most recent change of +$7.68 million (+40.44%) on June 30, 2025.
  • Over the past year, ACAD quarterly net income has dropped by -$6.72 million (-20.14%).
  • ACAD quarterly net income is now -81.45% below its all-time high of $143.74 million, reached on December 31, 2024.

Performance

ACAD quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADincome statement metrics

TTM net income:

$222.16M-$6.72M(-2.94%)
June 30, 2025

Summary

  • As of today (August 31, 2025), ACAD TTM net profit is $222.16 million, with the most recent change of -$6.72 million (-2.94%) on June 30, 2025.
  • Over the past year, ACAD TTM net income has increased by +$191.59 million (+626.84%).
  • ACAD TTM net income is now -2.94% below its all-time high of $228.88 million, reached on March 31, 2025.

Performance

ACAD TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

ACAD Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+469.5%-20.1%+626.8%
3 y3 years+234.9%+178.4%+208.6%
5 y5 years+196.3%+163.3%+198.7%

ACAD Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+204.8%-81.5%+140.9%-2.9%+202.2%
5 y5-yearat high+180.4%-81.5%+123.6%-2.9%+178.9%
alltimeall timeat high+178.3%-81.5%+123.6%-2.9%+171.8%

ACAD Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
$26.67M(+40.4%)
$222.16M(-2.9%)
Mar 2025
-
$18.99M(-86.8%)
$228.88M(+1.1%)
Dec 2024
$226.45M(-469.5%)
$143.74M(+338.7%)
$226.45M(+76.2%)
Sep 2024
-
$32.77M(-1.9%)
$128.51M(+320.4%)
Jun 2024
-
$33.39M(+101.7%)
$30.57M(-1887.4%)
Mar 2024
-
$16.55M(-63.9%)
-$1.71M(-97.2%)
Dec 2023
-$61.29M(-71.6%)
$45.80M(-170.3%)
-$61.29M(-58.8%)
Sep 2023
-
-$65.18M(-5950.6%)
-$148.81M(+34.3%)
Jun 2023
-
$1.11M(-102.6%)
-$110.81M(-24.1%)
Mar 2023
-
-$43.02M(+3.1%)
-$145.94M(-32.4%)
Dec 2022
-$215.97M(+28.7%)
-$41.73M(+53.5%)
-$215.97M(-0.6%)
Sep 2022
-
-$27.18M(-20.1%)
-$217.34M(+6.2%)
Jun 2022
-
-$34.01M(-69.9%)
-$204.62M(-4.6%)
Mar 2022
-
-$113.06M(+162.3%)
-$214.48M(+27.8%)
Dec 2021
-$167.87M(-40.4%)
-$43.09M(+198.1%)
-$167.87M(-12.4%)
Sep 2021
-
-$14.46M(-67.0%)
-$191.54M(-26.8%)
Jun 2021
-
-$43.87M(-34.0%)
-$261.74M(+0.7%)
Mar 2021
-
-$66.45M(-0.5%)
-$260.01M(-7.7%)
Dec 2020
-$281.58M(+19.7%)
-$66.76M(-21.1%)
-$281.58M(+5.1%)
Sep 2020
-
-$84.66M(+100.9%)
-$267.86M(+19.0%)
Jun 2020
-
-$42.14M(-52.1%)
-$225.18M(-5.4%)
Mar 2020
-
-$88.02M(+66.0%)
-$237.98M(+1.2%)
Dec 2019
-$235.26M(-4.1%)
-$53.04M(+26.3%)
-$235.26M(-5.0%)
Sep 2019
-
-$41.98M(-23.6%)
-$247.72M(-7.5%)
Jun 2019
-
-$54.94M(-35.6%)
-$267.88M(-3.0%)
Mar 2019
-
-$85.30M(+30.3%)
-$276.20M(+12.6%)
Dec 2018
-$245.19M(-15.3%)
-$65.49M(+5.4%)
-$245.19M(-1.4%)
Sep 2018
-
-$62.14M(-1.8%)
-$248.57M(-1.2%)
Jun 2018
-
-$63.27M(+16.5%)
-$251.68M(-1.6%)
Mar 2018
-
-$54.30M(-21.2%)
-$255.86M(-11.6%)
Dec 2017
-$289.40M(+6.6%)
-$68.87M(+5.6%)
-$289.40M(-3.3%)
Sep 2017
-
-$65.25M(-3.3%)
-$299.23M(-2.1%)
Jun 2017
-
-$67.44M(-23.2%)
-$305.59M(-1.3%)
Mar 2017
-
-$87.84M(+11.6%)
-$309.47M(+14.0%)
Dec 2016
-$271.39M(+65.0%)
-$78.70M(+9.9%)
-$271.39M(+13.8%)
Sep 2016
-
-$71.61M(+0.4%)
-$238.48M(+15.9%)
Jun 2016
-
-$71.32M(+43.3%)
-$205.77M(+18.4%)
Mar 2016
-
-$49.76M(+8.7%)
-$173.83M(+5.7%)
Dec 2015
-$164.44M(+77.8%)
-$45.78M(+17.7%)
-$164.44M(+11.8%)
Sep 2015
-
-$38.91M(-1.2%)
-$147.03M(+10.6%)
Jun 2015
-
-$39.38M(-2.5%)
-$132.91M(+15.5%)
Mar 2015
-
-$40.38M(+42.3%)
-$115.02M(+24.4%)
Dec 2014
-$92.47M(+143.7%)
-$28.37M(+14.4%)
-$92.47M(+21.4%)
Sep 2014
-
-$24.79M(+15.3%)
-$76.16M(+22.7%)
Jun 2014
-
-$21.50M(+20.6%)
-$62.07M(+25.0%)
Mar 2014
-
-$17.83M(+48.0%)
-$49.65M(+30.8%)
DateAnnualQuarterlyTTM
Dec 2013
-$37.95M(+82.0%)
-$12.05M(+12.7%)
-$37.95M(+16.0%)
Sep 2013
-
-$10.70M(+17.8%)
-$32.71M(+34.0%)
Jun 2013
-
-$9.08M(+48.3%)
-$24.42M(+17.6%)
Mar 2013
-
-$6.12M(-10.1%)
-$20.75M(-0.5%)
Dec 2012
-$20.85M(-8.4%)
-$6.81M(+183.5%)
-$20.85M(+7.8%)
Sep 2012
-
-$2.40M(-55.7%)
-$19.34M(-12.1%)
Jun 2012
-
-$5.42M(-12.8%)
-$22.01M(-4.9%)
Mar 2012
-
-$6.22M(+17.3%)
-$23.15M(+1.7%)
Dec 2011
-$22.77M(-250.4%)
-$5.30M(+4.4%)
-$22.77M(-295.0%)
Sep 2011
-
-$5.08M(-22.6%)
$11.68M(-6.8%)
Jun 2011
-
-$6.56M(+12.4%)
$12.53M(-15.3%)
Mar 2011
-
-$5.83M(-120.0%)
$14.79M(-2.3%)
Dec 2010
$15.14M(-133.5%)
$29.14M(-789.4%)
$15.14M(-166.7%)
Sep 2010
-
-$4.23M(-1.4%)
-$22.69M(-16.6%)
Jun 2010
-
-$4.29M(-21.9%)
-$27.19M(-23.7%)
Mar 2010
-
-$5.49M(-36.9%)
-$35.63M(-21.1%)
Dec 2009
-$45.15M(-29.7%)
-$8.69M(-0.4%)
-$45.15M(-10.5%)
Sep 2009
-
-$8.73M(-31.4%)
-$50.42M(-12.0%)
Jun 2009
-
-$12.73M(-15.2%)
-$57.31M(-8.8%)
Mar 2009
-
-$15.00M(+7.4%)
-$62.87M(-2.1%)
Dec 2008
-$64.24M(+13.9%)
-$13.96M(-10.6%)
-$64.24M(-4.6%)
Sep 2008
-
-$15.61M(-14.6%)
-$67.32M(-0.6%)
Jun 2008
-
-$18.29M(+11.6%)
-$67.75M(+12.5%)
Mar 2008
-
-$16.38M(-3.9%)
-$60.22M(+6.8%)
Dec 2007
-$56.39M(+25.0%)
-$17.04M(+6.2%)
-$56.39M(+8.9%)
Sep 2007
-
-$16.05M(+49.2%)
-$51.80M(+10.2%)
Jun 2007
-
-$10.75M(-14.3%)
-$47.02M(-2.3%)
Mar 2007
-
-$12.55M(+0.8%)
-$48.13M(+6.7%)
Dec 2006
-$45.10M(+32.1%)
-$12.45M(+10.5%)
-$45.10M(+5.2%)
Sep 2006
-
-$11.26M(-5.1%)
-$42.85M(-2.4%)
Jun 2006
-
-$11.87M(+24.7%)
-$43.89M(+15.3%)
Mar 2006
-
-$9.52M(-6.7%)
-$38.06M(+11.5%)
Dec 2005
-$34.14M(+97.0%)
-$10.20M(-17.1%)
-$34.14M(+9.2%)
Sep 2005
-
-$12.31M(+103.8%)
-$31.27M(+24.2%)
Jun 2005
-
-$6.04M(+8.0%)
-$25.18M(+14.9%)
Mar 2005
-
-$5.59M(-23.8%)
-$21.92M(+27.5%)
Dec 2004
-$17.33M(+855.7%)
-$7.33M(+18.0%)
-$17.19M(+74.4%)
Sep 2004
-
-$6.21M(+123.8%)
-$9.86M(+141.8%)
Jun 2004
-
-$2.78M(+220.9%)
-$4.08M(+142.4%)
Mar 2004
-
-$865.30K(+99.5%)
-$1.68M(+31.7%)
Dec 2003
-$1.81M(-44.1%)
-
-
Sep 2003
-
-$433.70K(+13.5%)
-$1.28M(+51.5%)
Jun 2003
-
-$382.20K(-17.0%)
-$842.70K(+83.0%)
Mar 2003
-
-$460.50K
-$460.50K
Dec 2002
-$3.25M(-10.2%)
-
-
Dec 2001
-$3.61M(+77.1%)
-
-
Dec 2000
-$2.04M
-
-

FAQ

  • What is ACADIA Pharmaceuticals Inc. annual net profit?
  • What is the all time high annual net income for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. annual net income year-on-year change?
  • What is ACADIA Pharmaceuticals Inc. quarterly net profit?
  • What is the all time high quarterly net income for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. quarterly net income year-on-year change?
  • What is ACADIA Pharmaceuticals Inc. TTM net profit?
  • What is the all time high TTM net income for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. TTM net income year-on-year change?

What is ACADIA Pharmaceuticals Inc. annual net profit?

The current annual net income of ACAD is $226.45M

What is the all time high annual net income for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high annual net profit is $226.45M

What is ACADIA Pharmaceuticals Inc. annual net income year-on-year change?

Over the past year, ACAD annual net profit has changed by +$287.74M (+469.50%)

What is ACADIA Pharmaceuticals Inc. quarterly net profit?

The current quarterly net income of ACAD is $26.67M

What is the all time high quarterly net income for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high quarterly net profit is $143.74M

What is ACADIA Pharmaceuticals Inc. quarterly net income year-on-year change?

Over the past year, ACAD quarterly net profit has changed by -$6.72M (-20.14%)

What is ACADIA Pharmaceuticals Inc. TTM net profit?

The current TTM net income of ACAD is $222.16M

What is the all time high TTM net income for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high TTM net profit is $228.88M

What is ACADIA Pharmaceuticals Inc. TTM net income year-on-year change?

Over the past year, ACAD TTM net profit has changed by +$191.59M (+626.84%)
On this page